Hot Topics

News

CRISPR-engineered T cells in Patients with Refractory Cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published in Science by researchers from the Abramson Cancer Center.

Read more
publication

CRISPR-engineered T cells in patients with refractory cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center.

Read more
publication

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia

An image from this article is featured on the cover of this edition of Blood Advances, a semimonthly medical journal published by the American Society of Hematology.  The cover figure of&

Read more
News

Penn's Gene Therapy Startup Raises Another $50 Million

Funding for cellular therapies that target specific B cells that mediate a wide variety of autoimmune conditions.

Read more
News

National Blood Foundation Early-Career Grant for Dr. Vijay Bhoj

Award for research in the fields of transfusion medicine and cellular therapies.

Read more
News

Stem Cell Lab Part of New Treatment for Lung Complications

Nationwide trial using adult stem cells to battle Acute Respiratory Distress Syndrome.

Read more